Latest News in the pharma Industry

Top Stories

Lilly to discontinue development of evacetrapib for high-risk atherosclerotic cardiovascular disease

Lilly to discontinue development of evacetrapib for high-risk atherosclerotic cardiovascular disease

12 Oct 2015

Phase III trial terminated due to insufficient efficacy.

Read more 
NIH grantees win 2015 Nobel Prize in chemistry

NIH grantees win 2015 Nobel Prize in chemistry

7 Oct 2015

Prize awarded for mapping, at a molecular level, how cells repair damaged DNA and safeguard the genetic information.

Read more 
FTC files amicus brief explaining that pharmaceutical “product hopping” can violate the antitrust laws

FTC files amicus brief explaining that pharmaceutical “product hopping” can violate the antitrust laws

2 Oct 2015

The FTC filed its amicus brief in a private antitrust action in which Mylan Phamraceuticals Inc. alleges that Warner Chilcott PLC/Mayne Pharma Group maintained a monopoly in the market for its antibiotic Doryx by suppressing generic competition through...

Read more 
National Biologics Manufacturing Centre launched

National Biologics Manufacturing Centre launched

1 Oct 2015

The new centre will provide companies with open access facilities and expertise to help them develop, prove and commercialise new and improved processes and technologies for biologics manufacture.

Read more 
CPhI Worldwide; shortlisted finalists for the 2015 Pharma Awards

CPhI Worldwide; shortlisted finalists for the 2015 Pharma Awards

23 Sep 2015

Winners from all 7 categories will be unveiled live at the event in Madrid.

Read more 
Swissmedic approves Novartis' new heart failure medicine Entresto

Swissmedic approves Novartis' new heart failure medicine Entresto

22 Sep 2015

Decision by Swiss Health Authority follows FDA approval of Entresto in July, and serves as an important reference approval for multiple other health authorities.

Read more 
FDA approves new drug to treat schizophrenia and bipolar disorder

FDA approves new drug to treat schizophrenia and bipolar disorder

22 Sep 2015

Vraylar is an atypical antipsychotic, for the acute treatment of manic or mixed episodes associated with bipolar I disorder and for treatment of schizophrenia in adults.

Read more 
Bausch + Lomb and Nicox announce FDA Acceptance of NDA for novel glaucoma candidate

Bausch + Lomb and Nicox announce FDA Acceptance of NDA for novel glaucoma candidate

22 Sep 2015

If approved, Vesneo will be the first nitric oxide donating prostaglandin receptor agonist available for patients with open angle glaucoma or ocular hypertension.

Read more 
Novo Nordisk to build manufacturing facility in Iran

Novo Nordisk to build manufacturing facility in Iran

22 Sep 2015

The plant will manufacture FlexPen prefilled devices.

Read more 
Envigo opens its doors for business on 21 September

Envigo opens its doors for business on 21 September

21 Sep 2015

Envigo has been created through the integration of Huntingdon Life Sciences, Harlan Laboratories, GFA, NDA Analytics and LSR associates.

Read more 
Targeting DNA — protein-based sensor could detect viral infection or kill cancer cells

Targeting DNA — protein-based sensor could detect viral infection or kill cancer cells

21 Sep 2015

MIT biological engineers have developed a modular system of proteins that can detect a particular DNA sequence in a cell and then trigger a specific response, such as cell death.

Read more 
Allergan confirms generic Rytary patent challenge

Allergan confirms generic Rytary patent challenge

21 Sep 2015

Allergan's ANDA product is a generic version of Impax Laboratories' Rytary.

Read more